510(k) Report

510(k) · Cleared

Cleared

Directpath

K121449510(k) TraditionalCleared Jul 10, 201256-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cybernet Systems Co., Ltd. · LLZ System, Image Processing, Radiological

Cleared on Jul 10, 2012 as substantially equivalent to K093810 (Kgt, Inc., 2010) and 1 other predicate after a 56-day review. Its family tree reaches back 10 generations to 1993. 1 of the 31 devices in its family, counting itself, has a Class I recall.

Decided
Jul 10, 2012
Review
56 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
2

Its longest line of descent runs back 10 generations to K926514 (1993). 30 ancestors in all, the oldest K882061 (1988). No later device cites it as a predicate yet. 1 of the 31 devices in this family, counting this one, has a Class I recall.

  1. Root · 10 generations backK926514 Endoscopic Ultrasound System Type 20Olympus Corp. · 1993 · Recalled
  2. 6 generations between
  3. 3 generations backK071473 Modification to Superdimension/Bronchus Premium 2Superdimension, Ltd. · 2007
  4. 2 generations backK080271 Inreach SystemSuperdimension, Ltd. · 2008
  5. 1 generation backK093810 BF-NaviKgt, Inc. · 2010
  6. This deviceK121449 DirectpathCybernet Systems Co., Ltd. · 2012
Show all 10 generations
  1. Root · 10 generations backK926514 Endoscopic Ultrasound System Type 20Olympus Corp. · 1993 · Recalled
  2. 9 generations backK951994 Olympus EU-M30 Endoscopic Ultrasound CenterOlympus America, Inc. · 1996
  3. 8 generations backK982323 Olympus UM 2R/3R Ultrasonic Probes and Associated Ancillary…Olympus America, Inc. · 1998
  4. 7 generations backK042438 Superdimension/BronchusSuperdimension, Ltd. · 2004 · Recalled
  5. 6 generations backK052260 Superdimension/Bronchus 4.1Superdimension, Ltd. · 2005 · Recalled
  6. 5 generations backK052852 Superdimension/Bronchus PremiumSuperdimension, Ltd. · 2005 · Recalled
  7. 4 generations backK062315 Superdimension/Bronchus Premium 2Superdimension, Ltd. · 2006 · Recalled
  8. 3 generations backK071473 Modification to Superdimension/Bronchus Premium 2Superdimension, Ltd. · 2007
  9. 2 generations backK080271 Inreach SystemSuperdimension, Ltd. · 2008
  10. 1 generation backK093810 BF-NaviKgt, Inc. · 2010
  11. This deviceK121449 DirectpathCybernet Systems Co., Ltd. · 2012

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−10K926514Endoscopic Ultrasound System Type 20Olympus Corp.19931
−9K951994Olympus EU-M30 Endoscopic Ultrasound CenterOlympus America, Inc.1996—
−8K982323Olympus UM 2R/3R Ultrasonic Probes and Associated Ancillary Equipment, for…Olympus America, Inc.1998—
−7K042438Superdimension/BronchusSuperdimension, Ltd.20041
−6K052260Superdimension/Bronchus 4.1Superdimension, Ltd.20052
−5K052852Superdimension/Bronchus PremiumSuperdimension, Ltd.20051
−4K062315Superdimension/Bronchus Premium 2Superdimension, Ltd.20061
−3K071473Modification to Superdimension/Bronchus Premium 2Superdimension, Ltd.2007—
−2K080271Inreach SystemSuperdimension, Ltd.2008—
−1K093810BF-NaviKgt, Inc.2010—
0 (this device)K121449DirectpathCybernet Systems Co., Ltd.2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198810
199110
199310
199520
199620
199830
199910
200020
200110
200210
200311
200510
200710
200820
FIG. 1 — Lineage of K121449, 1993–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K093810BF-Navi
Summary page 1
…choscopic Navigator Classification Name: Computed tomography x-ray system Classification Regulation: 892.1750 Product Code: JAK 5. Predicate Devices KGT Inc. - Bf-NAVI K09381 0 VIDAS Diagnostics - VIDA Pulmonary Workstation 2 (PW2) K083227 Cybernet Systems Co., Ltd. Traditional 510(k) Prem…
Kgt, Inc.2010—
*K083227Vida Pulmonary Workstation 2 (PW2)
Summary page 1
…ay system Classification Regulation: 892.1750 Product Code: JAK 5. Predicate Devices KGT Inc. - Bf-NAVI K09381 0 VIDAS Diagnostics - VIDA Pulmonary Workstation 2 (PW2) K083227 Cybernet Systems Co., Ltd. Traditional 510(k) Premarket Submission Direct Path 6. Device Description The DirectP…
Vida Diagnostics, Inc.2008—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K023984Modification to Olympus Bronchoscopes BF-40 Series, BF-240 Series, and BF-160 SeriesThe Olympus Optical Co. · 2003 · 4 generations back · ◆ in the 2003 ancestors bar of FIG. 114 Class I recalls

What does this lineage say?

  • The line of descent spans 19 years and passes through 5 companies; a new generation was cleared every 2.1 years on median.
  • 9 of the 30 ancestors have a recall of any class; 1 has a Class I recall.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

DirectPath is a virtual bronchoscopic navigation software program designed to assist the physician during bronchoscopic examination. The main purpose of the software is to generate a tracheobronchial tree using chest CT scan data in order to help the physician find an optimal bronchial route to the target region. The DirectPath software allows the physician to view a three-dimensional representation of the bronchial tree that displays virtual images of the inside surface of the bronchi. DirectPath is intended for use only as a guidance tool and does not make any medical diagnosis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K121449: Directpath.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K121449

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026